ATHIRA PHARMA INC. - COMMON STOCK
0.7001
14-November-24 11:02:45
15 minutes delayed
Stocks
-0.0299
-4.10%
Today's range
0.6928 - 0.7472
ISIN
N/A
Source
NASDAQ
-
Athira Pharma Reports Full Year 2022 Financial Results and Recent Pipeline and Business Updates
23 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at Upcoming Neuroscience Focused Investor Conferences
08 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer
31 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
Athira Pharma Provides 2023 Pipeline Outlook
05 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Publication of Fosgonimeton Preclinical Results in Neurotherapeutics
21 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Host Virtual R&D Event on December 7, 2022, from 2:00 –3:30 pm Eastern time
01 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2022 07:00:00 By Nasdaq GlobeNewswire
-
21 Nov 2022 07:00:00 By Nasdaq GlobeNewswire
-
16 Nov 2022 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
10 Nov 2022 16:05:04 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at Stifel 2022 Healthcare Conference
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
07 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
17 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
06 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
15 Aug 2022 16:05:02 By Nasdaq GlobeNewswire